Anti-tumor effects of 5-hydroxytryptamine (5-HT) are not entirely attributable to its effects on tumor vasculature.
Jenkins
D C
DC
Department of Molecular Sciences, Wellcome Research Laboratories, Beckenham, UK.
Wilkinson
J
J
Lindon
J C
JC
Farrant
R D
RD
Carpenter
T A
TA
Stables
J N
JN
Topley
P
P
Lindstead
D J
DJ
Holmes
L S
LS
D000230:Adenocarcinoma / Q000098:blood supply / Q000188:drug therapy*; D000818:Animals; D003110:Colonic Neoplasms / Q000098:blood supply / Q000188:drug therapy*; D004127:Dimethylhydrazines; D006801:Humans; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009374:Neoplasms, Experimental / Q000139:chemically induced / Q000188:drug therapy*; D012701:Serotonin / Q000494:pharmacology* / Q000627:therapeutic use; D014183:Transplantation, Heterologous
D004127:Dimethylhydrazines; D012701:Serotonin